This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Neurology  • Cerebrovascular Disease  • Stroke  • Psychiatry  • Depression  • Alert me on articles by topic  Social Bookmarking   What's this?

Anne-Marie Audet, MD; Erin E. Hartman, MS
From the Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, 330 Brookline Ave, LY318, Boston, MA 02215.

JAMA. 2001;285:80.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In November 1999, Robert G. Robinson, MD, discussed an 82-year-old woman who experienced symptoms of depression following a right internal capsular stroke.¹ The stroke left Mrs K, the patient, with a left-sided hemiparesis and restrictions in her activities of daily living. During the first 3 months after the acute stroke, she had episodic changes in her mood and behavior. She also had suicidal thoughts of wishing to die in her sleep. She expressed sadness and hopelessness and refused physical therapy. Her appetite was poor, and she had lost some weight. Dr W, her physician, initially prescribed fluoxetine hydrochloride for Mrs K, but had switched her medication to sertraline hydrochloride 1 month before the conference.

DR W, THE PHYSICIAN

Based on Dr Robinson's discussion, we changed Mrs K's drug therapy from sertraline to nortriptyline hydrochloride, and she has tolerated it well. Mrs K lost weight when taking sertraline, . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?